Fujian Yuanxiang New Materials Co.,Ltd

SZSE:301300 Stock Report

Market Cap: CN¥1.7b

Fujian Yuanxiang New MaterialsLtd Balance Sheet Health

Financial Health criteria checks 6/6

Fujian Yuanxiang New MaterialsLtd has a total shareholder equity of CN¥800.1M and total debt of CN¥20.0M, which brings its debt-to-equity ratio to 2.5%. Its total assets and total liabilities are CN¥981.8M and CN¥181.8M respectively. Fujian Yuanxiang New MaterialsLtd's EBIT is CN¥35.0M making its interest coverage ratio -4.2. It has cash and short-term investments of CN¥490.7M.

Key information

2.5%

Debt to equity ratio

CN¥20.01m

Debt

Interest coverage ratio-4.2x
CashCN¥490.70m
EquityCN¥800.06m
Total liabilitiesCN¥181.78m
Total assetsCN¥981.84m

Recent financial health updates

No updates

Recent updates

Fujian Yuanxiang New MaterialsLtd (SZSE:301300) Will Be Hoping To Turn Its Returns On Capital Around

Sep 30
Fujian Yuanxiang New MaterialsLtd (SZSE:301300) Will Be Hoping To Turn Its Returns On Capital Around

What Fujian Yuanxiang New Materials Co.,Ltd's (SZSE:301300) 54% Share Price Gain Is Not Telling You

Jul 12
What Fujian Yuanxiang New Materials Co.,Ltd's (SZSE:301300) 54% Share Price Gain Is Not Telling You

Fujian Yuanxiang New MaterialsLtd (SZSE:301300) Is Due To Pay A Dividend Of CN¥0.40

Jun 03
Fujian Yuanxiang New MaterialsLtd (SZSE:301300) Is Due To Pay A Dividend Of CN¥0.40

Fujian Yuanxiang New Materials Co.,Ltd's (SZSE:301300) Share Price Not Quite Adding Up

Feb 26
Fujian Yuanxiang New Materials Co.,Ltd's (SZSE:301300) Share Price Not Quite Adding Up

Financial Position Analysis

Short Term Liabilities: 301300's short term assets (CN¥793.9M) exceed its short term liabilities (CN¥175.3M).

Long Term Liabilities: 301300's short term assets (CN¥793.9M) exceed its long term liabilities (CN¥6.4M).


Debt to Equity History and Analysis

Debt Level: 301300 has more cash than its total debt.

Reducing Debt: 301300's debt to equity ratio has reduced from 41.4% to 2.5% over the past 5 years.

Debt Coverage: 301300's debt is well covered by operating cash flow (184%).

Interest Coverage: 301300 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies